Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India-Reference-Cited by-同舟云学术

Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India

Published:2022-07 Issue:7 Volume:22 Page:1052-1061
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Sehgal Inderpaul S,Dhooria Sahajal,Muthu Valliappan,Prasad Kuruswamy T,Aggarwal Ashutosh N,Chakrabarti Arunaloke,Choudhary Hansraj,Garg Mandeep,Agarwal Ritesh

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference30 articles.

1. Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America;Patterson;Clin Infect Dis,2016

2. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management;Denning;Eur Respir J,2016

3. Diagnostic cut-off of Aspergillus fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis;Sehgal;Mycoses,2018

4. An overview of the available treatments for chronic cavitary pulmonary aspergillosis;Sehgal;Expert Rev Respir Med,2020

5. Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation;Page;Eur Respir J,2019

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Features, Treatment Outcome and Potential risk Factors for Recurrence Among Patients with Chronic Pulmonary Aspergillosis in a Resource–limited Setting: A Retrospective Observational Study;Mycopathologia;2024-08-22

2. Serial Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (18FDG-PET-CT) in Assessing Treatment Response in Chronic Pulmonary Aspergillosis;The Journal of Infectious Diseases;2024-08-19

3. Optimized Antifungal Therapy for Chronic Pulmonary Aspergillosis;Medical Mycology Journal;2024-07-31

4. Aspergillus-assoziierte Erkrankungen aus infektiologischer und allergologischer Perspektive;Allergo Journal;2024-06

5. Innate and adaptive immune responses in subjects with CPA secondary to post‐pulmonary tuberculosis lung abnormalities;Mycoses;2024-05